Anumana unveils promising AI algorithm for early detection of pulmonary hypertension
Anumana, an AI-driven health technology leader and a portfolio company of nference, has announced significant advancements in pulmonary hypertension (PH) diagnosis through its latest study, ... Read More
Gradient Denervation raises €14m for pulmonary hypertension treatment
Gradient Denervation Technologies has successfully closed a €14 million Series A financing round to support the clinical development of its ultrasound-based catheter device for pulmonary ... Read More
Viz.ai partners with UCSF to commercialize AI algorithms for cardiovascular disease detection
Viz.ai, a frontrunner in artificial intelligence (AI) powered disease detection and intelligent care coordination, has inked an exclusive agreement with the University of California, San ... Read More
Zydus Lifesciences wins final FDA approval for pulmonary hypertension drug
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the ... Read More